Garrison Point Advisors’s Eli Lilly LLY Stock Holding History

Garrison Point Advisors’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$414K	Sell	345 -5	-1%	-$5.11K	0.17%	122
2026 Q1	$322K	Sell	350 -70	-17%	-$71K	0.15%	135
2025 Q4	$451K	Sell	420 -10	-2%	-$9.56K	0.2%	109
2025 Q3	$328K	Sell	430 -130	-23%	-$96.7K	0.14%	134
2025 Q2	$437K	Hold	560	–	–	0.2%	106
2025 Q1	$463K	Buy	560 +130	+30%	+$108K	0.22%	104
2024 Q4	$332K	Hold	430	–	–	0.16%	119
2024 Q3	$381K	Hold	430	–	–	0.24%	103
2024 Q2	$389K	Sell	430 -50	-10%	-$40K	0.26%	99
2024 Q1	$373K	Hold	480	–	–	0.24%	105
2023 Q4	$280K	Sell	480 -30	-6%	-$17.5K	0.2%	122
2023 Q3	$274K	Sell	510 -20	-4%	-$10.3K	0.21%	117
2023 Q2	$249K	Buy	+530	New	+$222K	0.18%	134
2023 Q1	–	Sell	-570	Closed	-$209K	–	156
2022 Q4	$209K	Buy	+570	New	+$202K	0.17%	137
2022 Q3	–	Sell	-640	Closed	-$208K	–	143
2022 Q2	$208K	Buy	+640	New	+$192K	0.17%	142

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Garrison Point Advisors's LLY Position: Q2 2026 in Review

Garrison Point Advisors reduced its Eli Lilly (LLY) stake by 1.4% in Q2 2026, selling an estimated $5.11K and leaving 345 shares worth $414K. The position accounts for 0.17% of the portfolio, ranked #122.

Garrison Point Advisors first reported a position in LLY in Q2 2022 and has held it in 15 quarters since. The position peaked at $463K in Q1 2025. 4,599 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

Garrison Point Advisors held 345 shares of Eli Lilly worth $414K as of Q2 2026.
Garrison Point Advisors sold 5 Eli Lilly shares in Q2 2026, an estimated $5.11K.
Eli Lilly made up 0.17% of Garrison Point Advisors's portfolio in Q2 2026, its #122 holding.
Garrison Point Advisors first reported a position in Eli Lilly in Q2 2022 and has held it in 15 quarters since.
Garrison Point Advisors's Eli Lilly position peaked at $463K in Q1 2025.
4,599 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Garrison Point Advisors's 13F filing for Q2 2026, filed 31 Jul 2026.